If your starter word contains a J, rethink your strategy. Here are the most commonly used letters in the alphabet. CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is ...

I don’t typically write responses to other opinion pieces, but there was one two weeks ago about new techniques in elementary math education that has inspired me. The main complaint was that there are ...

NEW YORK, Nov. 6, 2025 /PRNewswire/ -- Hannah Cranston Media (HCM), an award-winning PR and brand storytelling agency specializing in consumer brands, women's health, wellness, technology, and AI ...

Most people with HCM can participate in mild- to moderate-intensity exercise safely. When it comes to vigorous exercise and competitive sports, there may be a need for additional guidance from your ...

FPC is known for its expertise in payroll reconstruction, agency notice resolution, Employee Retention Credit (ERC) filings, and merger & acquisition compliance. By integrating FPC’s capabilities, HCM ...

MINNEAPOLIS — Readouts of data on an experimental drug for hypertrophic cardiomyopathies showed the agent appeared safe and effective in long-term treatment and can significantly improve exercise ...

CHARLOTTE, N.C. & STAMFORD, Conn.--(BUSINESS WIRE)--HCM II Acquisition Corp. (Nasdaq: HOND) (“HCM II”), a special-purpose acquisition company and Terrestrial ...

Oracle Corp. today announced a series of new agentic artificial intelligence extensions to its Fusion Cloud Human Capital Management suite, bringing the number of agents in the application to more ...

Panel A shows a cross-section of a normal heart (top) and an endomyocardial biopsy sample from a normal heart (bottom; with hematoxylin and eosin staining) that shows normal histologic characteristics ...

Mavacamten is approved to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). However, its effects in nonobstructive HCM remain uncertain. We conducted a phase 3, ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...